Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss can occur after treating diabetic ketoacidosis, especially with rapid weight loss and high soft drink intake.

COVID-19 can cause hair loss due to stress, with inflammation markers like D-dimer levels playing a role.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

COVID-19 can cause a temporary hair loss condition.

The study concludes that traction alopecia, caused by hair styling, can help understand telogen effluvium, a condition of excessive hair loss.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Homoeopathy has helped treat hair loss after Covid-19, considering the patient's overall condition.

Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.

Platelet-Rich Plasma therapy helped significantly in hair recovery for a hair loss condition after infection.

COVID-19 infection can cause temporary hair loss due to stress, treatment drugs, psychological impact, and pandemic-related stress.

COVID-19 infection may cause hair loss a few months after recovery.

COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.

Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

The marine protein complex, Viviscal®, was found to effectively reduce hair loss and improve hair, skin, and nails quality in women.

Horizontally sectioned scalp biopsies are more reliable for diagnosing hair loss in women when three samples are taken instead of one.

Hair loss in a drug reaction case involved both a common shedding phase and an immune attack on hair follicle stem cells.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

COVID-19 can cause different types of hair loss, which may last up to 100 days, and treatments are still being explored.

COVID-19 may cause a common type of hair loss called telogen effluvium.

Finasteride slightly better long-term, minoxidil faster initial results, but stopping minoxidil may cause hair loss.

The authors suggest that a new type of hair loss exists, which is different from alopecia areata.

Low iron levels are strongly linked to chronic hair loss in women.

The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.